The unique properties of nanomaterials—such as their size, shape, surface area, and reactivity—differ significantly from their bulk counterparts. These differences necessitate tailored regulatory approaches to ensure safety, efficacy, and ethical considerations. Traditional regulatory frameworks often fail to account for the unique risks and benefits associated with nanotechnology.
